Persistent sputum eosinophilia in patients with difficult-to-treat asthma

F. L. Dente, G. Spoletini, F. Novelli, A. Di Franco, E. Bacci, F. Baliva, M. L. Bartoli, S. Cianchetti, P. L. Paggiaro (Italy)

Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up
Session: Asthma aspect of diagnosis and criteria for follow-up
Session type: Thematic Poster Session
Number: 532
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. L. Dente, G. Spoletini, F. Novelli, A. Di Franco, E. Bacci, F. Baliva, M. L. Bartoli, S. Cianchetti, P. L. Paggiaro (Italy). Persistent sputum eosinophilia in patients with difficult-to-treat asthma. Eur Respir J 2010; 36: Suppl. 54, 532

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predictors of sputum eosinophilia in severe asthma
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Year: 2020


Sputum eosinophilia in patients with chronic cough
Source: Eur Respir J 2007; 30: Suppl. 51, 585s
Year: 2007

Induced sputum concentrations of mucin in patients with asthma and chronic cough
Source: Eur Respir J 2007; 30: Suppl. 51, 61s
Year: 2007

Sputum eosinophilia in the diagnosis and management of asthma of moderate severity in adults
Source: Eur Respir J 2007; 30: Suppl. 51, 587s
Year: 2007

Induced sputum in children with mild-to-moderate atopic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 143s
Year: 2002

Sputum eosinophils and bronchial hyperreactivity in patients with chronic cough
Source: Eur Respir J 2005; 26: Suppl. 49, 479s
Year: 2005

Inflammatory markers in sputum of patients with cough variant asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 584s
Year: 2002

Heterogeneous response of airway eosinophilia to biologics in severe asthma patients
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021


Asthma and persistent low sputum eosinophilia
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009

Longitudinal variability of pulmonary function and sputum eosinophilia in severe refractory asthmatics
Source: Eur Respir J 2003; 22: Suppl. 45, 479s
Year: 2003

Cytokine profile in sputum from non-infective exacerbation of COPD and non-atopic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 252s
Year: 2002

Changes in patients perception of dyspnoea, sputum volume and sputum purulence during treatment of chronic bronchitis exacerbations
Source: Eur Respir J 2001; 18: Suppl. 33, 213s
Year: 2001

Follow-up of sputum eosinophils and cytokines during and out of exacerbations in severe refractory asthmatics
Source: Eur Respir J 2004; 24: Suppl. 48, 594s
Year: 2004

Bronchial challenge test in patients with chronic persistent cough and asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 475s
Year: 2003

Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020


Induced sputum to assess bronchial inflammation in children with intermittent athopic asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 399s
Year: 2003

Treating rhinitis in patients with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 425s
Year: 2001

Induced sputum eosinophils, bronchial reactivity and cough sensitivity in allergic rhinitis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 583s
Year: 2005

Mepolizumab efficacy in patients with severe eosinophilic asthma and bronchiectasis
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019

Factors driving airway eosinophilia in prednisone-dependent severe asthma
Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma
Year: 2017